LOFARMA S.p.A (full production cycle: manufacturing, primary packaging, secondary packaging, batch control, batch release, storage)
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of rhinitis, conjunctivitis, and allergic bronchial asthma caused by ragweed pollen, provided that clinical symptoms are present and the allergy is confirmed.
Dosage form: tablets, sublingual
Active substance Dosage chemically modified allergen extract of ambrosia artemisiifolia pollen 300 IU or 1000 IU ATC: V01AA
-
The drug is used for the treatment of allergic rhinitis, conjunctivitis, and allergic bronchial asthma caused by birch and alder pollen.
Dosage form: tablets, sublingual
Active substance Dosage mixture of chemically modified allergenic extracts of pollen of birch and alder 300 IU or 1000 IU ATC: V01AA